Novel chimeric antigen receptor-expressing T cells targeting the malignant mesothelioma-specific antigen sialylated HEG1.
Kouro T, Higashijima N, Horaguchi S, Mano Y, Kasajima R, Xiang H, Fujimoto Y, Kishi H, Hamana H, Hoshino D, Himuro H, Matsuura R, Tsuji S, Imai K, Sasada T.
Kouro T, et al. Among authors: sasada t.
Int J Cancer. 2024 May 15;154(10):1828-1841. doi: 10.1002/ijc.34843. Epub 2024 Jan 11.
Int J Cancer. 2024.
PMID: 38212893